SG10202105500VA - Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer - Google Patents

Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer

Info

Publication number
SG10202105500VA
SG10202105500VA SG10202105500VA SG10202105500VA SG10202105500VA SG 10202105500V A SG10202105500V A SG 10202105500VA SG 10202105500V A SG10202105500V A SG 10202105500VA SG 10202105500V A SG10202105500V A SG 10202105500VA SG 10202105500V A SG10202105500V A SG 10202105500VA
Authority
SG
Singapore
Prior art keywords
combination
treating cancer
inorganic nanoparticles
ionizing radiations
nanoparticles compositions
Prior art date
Application number
SG10202105500VA
Inventor
Elsa Borghi
Laurent Levy
Agnès Pottier
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of SG10202105500VA publication Critical patent/SG10202105500VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG10202105500VA 2013-01-25 2014-01-24 Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer SG10202105500VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361756533P 2013-01-25 2013-01-25
EP13305087 2013-01-25

Publications (1)

Publication Number Publication Date
SG10202105500VA true SG10202105500VA (en) 2021-07-29

Family

ID=67296872

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10202105500VA SG10202105500VA (en) 2013-01-25 2014-01-24 Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer

Country Status (9)

Country Link
DK (1) DK2948179T3 (en)
ES (1) ES2734493T3 (en)
HR (1) HRP20191272T1 (en)
HU (1) HUE045407T2 (en)
LT (1) LT2948179T (en)
NZ (2) NZ709685A (en)
PT (1) PT2948179T (en)
SG (1) SG10202105500VA (en)
TR (1) TR201910251T4 (en)

Also Published As

Publication number Publication date
NZ709685A (en) 2019-10-25
HUE045407T2 (en) 2019-12-30
HRP20191272T1 (en) 2019-10-18
TR201910251T4 (en) 2019-07-22
LT2948179T (en) 2019-08-12
DK2948179T3 (en) 2019-07-22
PT2948179T (en) 2019-07-19
NZ750194A (en) 2020-02-28
ES2734493T3 (en) 2019-12-10

Similar Documents

Publication Publication Date Title
HK1216609A1 (en) Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer
IL245281A0 (en) Methods and compositions for treating cancer
IL245731A0 (en) Combination therapy for treating cancer
IL242881B (en) Cytotoxic substance for use in combination with radiotherapy in cancer treatment
SG11201510751YA (en) Composition and vaccine for treating prostate cancer
EP2968343A4 (en) Combination therapy for treating cancer
IL244353A0 (en) Compounds and use for treating cancer
HK1255453A1 (en) Methods and compositions for treating leukemia
HK1225647A1 (en) Compositions and methods for treating cancers
EP3004395A4 (en) Compositions and methods for treating cancer
HK1222561A1 (en) Compositions and methods for use in oncology
HUE049301T2 (en) Curcuphenol compound for use in treating cancer
EP2984185A4 (en) Methods and compositions for treating cancer
EP2968390A4 (en) Injectable formulations for treating cancer
GB201308753D0 (en) Compounds and their use in therapy
IL243091B (en) Compositions and methods for use in oncology
SG10202105500VA (en) Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer
EP2971044A4 (en) Compositions and methods for treating cancer
EP2968398A4 (en) Modified hyaluronan and uses thereof in cancer treatment
TH1501004170A (en) Inorganic nanoparticle composition combined with ionizing radiation for cancer treatment
GB201319951D0 (en) Treating Particle
GB201322958D0 (en) Uses of oligouronates in cancer treatment
GB201308217D0 (en) Compounds and their use in therapy
GB201302064D0 (en) Improvements in pacemakers